1. Stocks
  2. X.T.L. Biopharmaceuticals Ltd. - ADR
  3. Swot
swot-logo

X.T.L. Biopharmaceuticals Ltd. - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

X.T.L. Biopharmaceuticals Ltd. - ADR has 9 Strengths, 13 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Third Resistance ( LTP > R3)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Positive Breakout (LTP > R2)

Positive breakout third resistance ( LTP > R3)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Near 52 Week Low

Low Piotroski Score : Companies with weak financials

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Institutions decreased their shareholding last quarter